News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Using Early On-treatment Circulating Tumor DNA Measurements as Response Assessment in Metastatic Castration Resistant Prostate Cancer

News

July 17, 2024
PRESS RELEASE: On July 2, 2024, a new editorial was published in Oncotarget, entitled, “Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer.” continue reading »

HER2-low and HER2-zero in Breast Cancer Between Prognosis, Prediction and Entity

News

July 16, 2024
PRESS RELEASE: On June 20, 2024, a new editorial was published in Oncotarget, entitled, “HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.” continue reading »

Roles of PEDF in Exercise-induced Suppression of Senescence and its Impact on Lung Pathology in Mice

Aging

July 16, 2024
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 13, entitled, “Roles of pigment epithelium-derived factor in exercise-induced suppression of senescence and its impact on lung pathology in mice.” continue reading »

Comparison of FDG-PET/CT and CT for Treatment Evaluation of Patients With Unresectable Malignant Pleural Mesothelioma

Oncotarget

July 15, 2024
PRESS RELEASE: On June 20, 2024, a new research paper was published in Oncotarget, entitled, “Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.” continue reading »

Entering the Golden Age for Antibody-drug Conjugates in Gynecologic Cancer

Oncoscience

July 12, 2024
PRESS RELEASE: On May 20, 2024, a new editorial was published in Oncoscience, entitled, “Entering the golden age for antibody-drug conjugates in gynecologic cancer.” continue reading »